(Q44185032)
Statements
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24) (English)
G G Steger
R Greil
A Lang
M Rudas
B Mlineritsch
B L Hartmann
R Bartsch
E Melbinger
M Hubalek
H Stoeger
P Dubsky
S Ressler
A L Petzer
C F Singer
C Muss
R Jakesz
S P Gampenrieder
C C Zielinski
C Fesl
Austrian Breast and Colorectal Study Group (ABCSG)